CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Prif Awdur: | Eva, Israt Ara Jannat |
|---|---|
| Awduron Eraill: | Rahman, Kazi Fatema |
| Fformat: | Traethawd Ymchwil |
| Iaith: | English |
| Cyhoeddwyd: |
Brac University
2023
|
| Pynciau: | |
| Mynediad Ar-lein: | http://hdl.handle.net/10361/17764 |
Eitemau Tebyg
-
A review on CRISPR-Cas system based applications in Oncology
gan: Sadia, Mir
Cyhoeddwyd: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
gan: Maria, Amatul
Cyhoeddwyd: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
gan: Nwabunwanne, Eze Uchenna
Cyhoeddwyd: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
gan: Shaikat, Mahdi Mubin
Cyhoeddwyd: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
gan: Ullah, Mohammad
Cyhoeddwyd: (2023)